Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
A 56-year old male with type 2 diabetes and stage 3 chronic kidney disease contacted us recently regarding his new prescription for the SGLT2 inhibitor canagliflozin (Invokana)....
Read More »SGLT2 Inhibitors for Kidney Disease
Diabetes Prevention: The Key To Reducing End-stage Kidney Disease
Earlier onset of type 2 diabetes equals higher risk of kidney transplant.
Read More »Risks Associated with Age of Diabetes Onset
Compelling evidence suggests that the age of diabetes diagnosis may be linked to the risk of end-stage kidney disease.
Read More »Life Expectancy With CVD, CKD, and Diabetes
Explore the detriments associated with two of the most common diabetes comorbidities.
Read More »A Link Between ESRD and Low BMI
Study of BMI and ESRD suggests obesity may provide a health benefit when it comes to end-stage renal disease.
Read More »Renal Disease Impact On Long-Term Metformin Use
As we are all familiar with how metformin can impact patients with existing renal disease, researchers aimed to study how far the limitations can be pushed.
Read More »Prediabetes and Risk for CKD
People with prediabetes and diabetes are at a higher risk of developing chronic kidney disease (CKD) as well as chronic cardiovascular diseases.
Read More »Diabetes May Be a Risk Factor in All-Cause Mortality
Individuals with a high glucose variability are at risk of developing high-mortality conditions such as arteriosclerosis and sustained hyperglycemic episodes.
Read More »Diabetic Kidney Disease Prevention
A new study in Japan researched the association between HbA1c levels and body mass index, and its effect on the kidney.
Read More »Risk Factors for Advanced Kidney Disease in Patients with Type 1 Diabetes
How to identify who is at risk for the progression of diabetic kidney disease to end-stage renal disease?
Read More »